These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 16184720)

  • 1. Autocrine motility factor receptor expression implies an unfavourable prognosis in resected stage I pulmonary adenocarcinomas.
    Kaynak K; Kara M; Oz B; Akgoz B; Sar M; Raz A
    Acta Chir Belg; 2005 Aug; 105(4):378-82. PubMed ID: 16184720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autocrine motility factor receptor expression in patients with stage I non-small cell lung cancer.
    Kara M; Ohta Y; Tanaka Y; Oda M; Watanabe Y
    Ann Thorac Surg; 2001 Mar; 71(3):944-8. PubMed ID: 11269478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of cell motility activation factors in patients with tongue squamous cell carcinoma.
    Endo K; Shirai A; Furukawa M; Yoshizaki T
    Hum Pathol; 2006 Aug; 37(8):1111-6. PubMed ID: 16867875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated expression of autocrine motility factor receptor correlates with overexpression of RhoC and indicates poor prognosis in hepatocellular carcinoma.
    Wang W; Yang LY; Yang ZL; Peng JX; Yang JQ
    Dig Dis Sci; 2007 Mar; 52(3):770-5. PubMed ID: 17265125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant expression of the autocrine motility factor receptor correlates with poor prognosis and promotes metastasis in gastric carcinoma.
    Huang Z; Zhang N; Zha L; Mao HC; Chen X; Xiang JF; Zhang H; Wang ZW
    Asian Pac J Cancer Prev; 2014; 15(2):989-97. PubMed ID: 24568530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of autocrine motility factor (AMF) and its receptor, AMFR, in human breast cancer.
    Jiang WG; Raz A; Douglas-Jones A; Mansel RE
    J Histochem Cytochem; 2006 Feb; 54(2):231-41. PubMed ID: 16204225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between loss of E-cadherin expression and overexpression of autocrine motility factor receptor in association with progression of human gastric cancers.
    Kawanishi K; Doki Y; Shiozaki H; Yano M; Inoue M; Fukuchi N; Utsunomiya T; Watanabe H; Monden M
    Am J Clin Pathol; 2000 Feb; 113(2):266-74. PubMed ID: 10664629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of autocrine motility factor receptor gene expression as a prognostic factor in non-small-cell lung cancer.
    Takanami I; Takeuchi K; Watanabe H; Yanagawa T; Takagishi K; Raz A
    Int J Cancer; 2001 Nov; 95(6):384-7. PubMed ID: 11668522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autocrine motility factor receptor: a clinical review.
    Chiu CG; St-Pierre P; Nabi IR; Wiseman SM
    Expert Rev Anticancer Ther; 2008 Feb; 8(2):207-17. PubMed ID: 18279062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The gene product of the gp78/AMFR ubiquitin E3 ligase cDNA is selectively recognized by the 3F3A antibody within a subdomain of the endoplasmic reticulum.
    Registre M; Goetz JG; St Pierre P; Pang H; Lagacé M; Bouvier M; Le PU; Nabi IR
    Biochem Biophys Res Commun; 2004 Aug; 320(4):1316-22. PubMed ID: 15303277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autocrine motility factor in pulmonary adenocarcinomas: results of an immunohistochemical study.
    Takanami I; Takeuchi K; Naruke M; Kodaira S; Tanaka F; Watanabe H; Raz A
    Tumour Biol; 1998; 19(5):384-9. PubMed ID: 9701729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autocrine motility factor receptor expression associates with tumor progression in thymoma.
    Ohta Y; Minato H; Tanaka Y; Go T; Oda M; Watanabe Y
    Int J Oncol; 2000 Aug; 17(2):259-64. PubMed ID: 10891533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relation between the growth patterns of gastric carcinoma and the expression of hepatocyte growth factor receptor (c-met), autocrine motility factor receptor, and urokinase-type plasminogen activator receptor.
    Taniguchi K; Yonemura Y; Nojima N; Hirono Y; Fushida S; Fujimura T; Miwa K; Endo Y; Yamamoto H; Watanabe H
    Cancer; 1998 Jun; 82(11):2112-22. PubMed ID: 9610690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The autocrine motility factor (AMF) and AMF-receptor combination needs sugar chain recognition ability and interaction using the C-terminal region of AMF.
    Haga A; Tanaka N; Funasaka T; Hashimoto K; Nakamura KT; Watanabe H; Raz A; Nagase H
    J Mol Biol; 2006 May; 358(3):741-53. PubMed ID: 16563432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autocrine motility factor-receptor gene expression in lung cancer.
    Takanami I; Takeuchi K
    Jpn J Thorac Cardiovasc Surg; 2003 Aug; 51(8):368-73. PubMed ID: 12962414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of autocrine motility factor receptor correlates with disease progression in human gastric cancer.
    Hirono Y; Fushida S; Yonemura Y; Yamamoto H; Watanabe H; Raz A
    Br J Cancer; 1996 Dec; 74(12):2003-7. PubMed ID: 8980404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of autocrine motility factor receptor (AMFR) in NIH3T3 fibroblasts induces cell transformation.
    Onishi Y; Tsukada K; Yokota J; Raz A
    Clin Exp Metastasis; 2003; 20(1):51-8. PubMed ID: 12650607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The complex biology of autocrine motility factor/phosphoglucose isomerase (AMF/PGI) and its receptor, the gp78/AMFR E3 ubiquitin ligase.
    Fairbank M; St-Pierre P; Nabi IR
    Mol Biosyst; 2009 Aug; 5(8):793-801. PubMed ID: 19603112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of autocrine motility factor receptor expression by colorectal cancer and lymph node metastases.
    Halwani Y; Kojic LD; Chan SK; Phang TP; Masoudi H; Jones SJ; Nabi IR; Wiseman SM
    Am J Surg; 2015 May; 209(5):884-9; discussion 889. PubMed ID: 25852009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of autocrine motility factor receptor in cutaneous malignant melanoma.
    Nagai Y; Ishikawa O; Miyachi Y; Watanabe H
    Dermatology; 1996; 192(1):8-11. PubMed ID: 8832943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.